Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
Year: 2019
Type: article
Study design: Clinical Trial
Source: Targeted Oncology
Institution: The University of Texas Southwestern Medical Center
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Peregrine Pharmaceuticals
OpenAlex ID: W2969756092
